Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2020
A Randomized Trial of Two 2-Dose Influenza Vaccination Strategies for Patients Following Autologous Hematopoietic Stem Cell TransplantationBenjamin W Teh, Vivian K Y Leung, Francesca L Mordant, et al.
Pediatric Blood & Cancer|December 2, 2021
Cost-effectiveness of home-based care of febrile neutropenia in children with cancerMichelle Tew, Richard De Abreu Lourenco, Joshua Robert Gordon, et al.
Internal Medicine Journal|April 24, 2023
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myelomaBenjamin W Teh, Gemma Reynolds, Monica A Slavin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2026
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort studyGemma K Reynolds, Mark R Dowling, Safia Belbachir, et al.
Open Forum Infectious Diseases|December 8, 2025
Severity of Respiratory Syncytial Virus and Other Respiratory Viruses Versus Seasonal Influenza Among Hospitalized Patients With CancerLiang En Wee, Leicester Shawn Alcantara, May Kyawt Aung, et al.
Human Vaccines & Immunotherapeutics|April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccinesSally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
Ejhaem|February 23, 2023
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapyThi H O Nguyen, Chhay Lim, Masa Lasica, et al.
The Lancet. Infectious Diseases|September 8, 2023
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patientsBenjamin W Teh, Malgorzata Mikulska, Dina Averbuch, et al.
Open Forum Infectious Diseases|November 29, 2023
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-CilgavimabVictoria G Hall, Thi H O Nguyen, Lilith F Allen, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Pageof 7